chr2-190995209-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 3P and 12B. PM1PP2BP4_StrongBS1BS2
The NM_007315.4(STAT1):c.796G>A(p.Val266Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00314 in 1,613,894 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_007315.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STAT1 | NM_007315.4 | c.796G>A | p.Val266Ile | missense_variant | 10/25 | ENST00000361099.8 | NP_009330.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STAT1 | ENST00000361099.8 | c.796G>A | p.Val266Ile | missense_variant | 10/25 | 1 | NM_007315.4 | ENSP00000354394.4 |
Frequencies
GnomAD3 genomes AF: 0.00241 AC: 367AN: 152024Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00237 AC: 597AN: 251406Hom.: 3 AF XY: 0.00234 AC XY: 318AN XY: 135874
GnomAD4 exome AF: 0.00322 AC: 4705AN: 1461752Hom.: 15 Cov.: 31 AF XY: 0.00315 AC XY: 2292AN XY: 727180
GnomAD4 genome AF: 0.00241 AC: 367AN: 152142Hom.: 0 Cov.: 31 AF XY: 0.00251 AC XY: 187AN XY: 74364
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2024 | STAT1: PP2, BP4, BS3:Supporting, BS2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jun 19, 2020 | - - |
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency Pathogenic:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 04, 2018 | - - |
Immunodeficiency 31B;C3279990:Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome;C4013950:Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Mar 30, 2021 | STAT1 NM_007315.3 exon 10 p.Val266Ile (c.796G>A): This variant has been reported in the literature as a heterozygous variant in at least 8 individuals with varying [inconsistent?] immunodeficiency phenotypes (Uzel 2013 PMID:23534974, Mork 2015 PMID:26513235, Remaschi 2015 PMID:26162368, Szymanski 2015 PMID:26038974, Depner 2016 PMID:26604104, Rae 2018 PMID:29077208). This variant is present in 0.6% (175/25748) of European alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/2-191859935-C-T) and is present in ClinVar with conflicting interpretations ranging from likely benign to pathogenic (Variation ID:333285). Functional studies are also conflicting; one study using flow cytometric anaylsis showed a significant increase in STAT1 phosphorylation with this variant compared to the wildtype, which is consistent with a gain of function effect (Uzel 2013 PMID:23534974). However, a second study using similar methodology showed no evidence for hyperphosphorylation of STAT1 with this variant (Depner 2016 PMID:26604104). This variant amino acid Isoleucine (Ile) is present in several species and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
STAT1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 01, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Immunodeficiency 31B Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at